Clinical Trial Update: To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study assessing whether chromium nicotinate supplementation improves insulin resistance in HIV-infected patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Insulin Resistance

Drugs mentioned

• Chromium nicotinate (Chromium(III) nicotinate)

Snippet

Sponsor: Johane Allard | Conditions: HIV Infections | Phase 2 | Status: COMPLETED